TABLE 2.
Vaccine | Virus titer/eyeb (n) | Range of virus titer/eyec | Days to clear virusd |
---|---|---|---|
vP35 | 67 ± 19 (100) | 0-175 | 5 |
vP40 | 114 ± 34 (160) | 0-1400 | 8 |
vP35+vP40 | 84 ± 15 (120) | 0-420 | 6 |
vIL-4 | 86 ± 26 (100) | 0-800 | 5 |
dbl-p | 231 ± 120 (160) | 0-4000 | 8 |
KOS | 106 ± 33 (120) | 0-1800 | 6 |
Mock | 2,886 ± 504 (180) | 0-21160 | 9 |
BALB/c mice were immunized three times with each virus or mock immunized as described in Materials and Methods. At 3 weeks after the third immunization, mice were challenged ocularly with 2 × 105 PFU of HSV-1 strain McKrae/eye. Tears were collected from days 1 to 10 postinfection from 20 eyes/group from two separate experiments, and the amount of virus was determined by plaque assay. Numbers in parentheses (n) indicate the number of eyes used to determine the virus titer/eye.
The data represent the mean of the virus titer/eye from day 1 until the virus was completely cleared from all of the eyes ± the SEM.
Range of virus titer/eye from day 1 until the virus was cleared.
That is, the number of days required to completely clear the virus from the eyes of challenged mice.